Rajesh Marwaha
Corporate Officer/Principal bij The Institute of Chartered Accountants of India
Profiel
Rajesh Marwaha is a Member of The Institute of Chartered Accountants of India and currently holds a position there.
He was previously the Chief Financial Officer & Executive Director at AstraZeneca Pharma India Ltd.
from 2016 to 2023 and the Chief Financial Officer & Head-Investor Relations at Fulford (India) Ltd.
in 2013.
He also worked as a Controller-Sales & Commercial Division at Groupe Seb SA (United Arab Emirates).
Actieve functies van Rajesh Marwaha
| Bedrijven | Functie | Begin |
|---|---|---|
| The Institute of Chartered Accountants of India | Corporate Officer/Principal | - |
Eerdere bekende functies van Rajesh Marwaha
| Bedrijven | Functie | Einde |
|---|---|---|
| ASTRAZENECA PHARMA INDIA LIMITED | Director of Finance/CFO | 30-09-2023 |
| FULFORD (INDIA) LIMITED | Director of Finance/CFO | 02-08-2013 |
| Groupe Seb SA (United Arab Emirates) | Sales & Marketing | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ASTRAZENECA PHARMA INDIA LIMITED | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Fulford (India) Ltd.
 Fulford (India) Ltd. Pharmaceuticals: MajorHealth Technology Fulford (India) Ltd. engages in the wholesale of pharmaceutical and medical goods. Its products include speciality health care and fertility, oncology, quadriderm, elocon, elosalic, dipsalic, and emolene. The company was founded on March 2, 1948 and is headquartered in Mumbai, India. | Health Technology |
| Groupe Seb SA (United Arab Emirates) |
